Novel antithrombotic approaches in cardiovascular disease – what is on the horizon?
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1281, doi. 10.1007/s11239-024-03062-2
- By:
- Publication type:
- Article
Works matching IS 09295305 AND DT 2024 AND VI 57 AND IP 8
Results: 9
1
2
The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1339, doi. 10.1007/s11239-024-03059-x
- By:
- Publication type:
- Article
3
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1308, doi. 10.1007/s11239-024-03054-2
- By:
- Publication type:
- Article
4
Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1329, doi. 10.1007/s11239-024-03040-8
- By:
- Publication type:
- Article
5
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice: RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice: S. Ma et al.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1349, doi. 10.1007/s11239-024-03034-6
- By:
- Publication type:
- Article
6
The potential role of factor XI inhibitors in managing long COVID.
- Published in:
- 2024
- By:
- Publication type:
- Letter
7
Factor XIa inhibition as a therapeutic strategy for atherothrombosis.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1297, doi. 10.1007/s11239-024-03023-9
- By:
- Publication type:
- Article
8
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease: The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease: Ali and Becker.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1283, doi. 10.1007/s11239-024-02985-0
- By:
- Publication type:
- Article
9
Factor XI: structure, function and therapeutic inhibition: Factor XI: structure, function and therapeutic inhibition: A. E. Ali et al.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2024, v. 57, n. 8, p. 1315, doi. 10.1007/s11239-024-02972-5
- By:
- Publication type:
- Article